drugset / Trial / NCT06600529

Combined Photo-Biomodulation At Acupuncture Points, Autologous PRP, and Umbilical Cord-Derived Exosome Therapy in Autism Spectrum Disorder

NCT06600529 ↗

Recruiting 100 enrolled Iffat Anwar Medical Complex
RandomizedParallel-groupSingle-blindTreatment

Summary

This randomized controlled trial aims to evaluate the efficacy of a combination of photo-biomodulation at acupuncture points, autologous platelet-rich plasma (PRP), and umbilical cord-derived exosome therapy in children with Autism Spectrum Disorder (ASD). The study will compare these interventions against standard care to determine their impact on the severity of autism symptoms, as measured by the Childhood Autism Rating Scale (CARS) and other related markers.

Timeline

Start
2024-08-13
Primary completion
2025-06-10
Completion
2025-12-13

Drugs

EvaluationDrugModalityDoseRoute
Subject Autologous Plasma Rich Platelets (PRP) Unknown — Intravenous
Subject Umbilical Cord-Derived Exosomes Other / unclassified — Intravenous